You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | n/a |
| Div Cover | n/a | n/a |
| Op Mrgn | -5,491.7% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | 0.6 | n/a |
| PEG | -0.1 | n/a |
| Price / Revenue | 57.0 | n/a |
| Price / Book value | 1.6 |
| Latest | Forecast | |
|---|---|---|
| Revenue | -7.7% | 0.0% |
| PBT | 0.0% | n/a |
| EPS | -5.2% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2018-12-31 | 0.08 | -7.96 | -5.19p | -2.3 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | 0.08 | -6.74 | -3.99p | -4.0 | 0.0 | n/a | n/a | 0.0% |
| 2020-12-31 | 0.13 | -7.25 | 3.43p | 3.9 | 0.0 | n/a | n/a | 0.0% |
| 2021-12-31 | 0.12 | -8.94 | 3.25p | 2.0 | -0.4 | -5% | n/a | 0.0% |
| ImmuPharma upbeat after meeting with US partner Avion Sharecast News | 11 Nov |
|---|---|
| ImmuPharma's US partner receives FDA response on Lupuzor Sharecast News | 14 Sep |
| ImmuPharma making final preparations for Lupuzor phase 3 trial Sharecast News | 04 May |
| Lupuzor™ Update | 27-Mar-23 14:40 |
|---|---|
| Price Monitoring Extension | 09-Mar-23 23:59 |
| Collaboration with Orano on ImmuPharma Peptide | 06-Mar-23 15:04 |
| Lupuzor™ Update | 06-Feb-23 14:15 |
| TR-1: Notification of major holdings | 27-Jan-23 23:59 |